Oestrogen is the major stimulatory factor in endometrial cell proliferation. Animal and in-vitro studies have shown that proto-oncogenes c-fos and c-y'un are regulated by oestrogen receptor (ER) complex. We have previously shown by Northern blot analysis that proto-oncogenes c-fos and c-jun are strongly expressed in human proliferative and early to mid-secretory endometrium. In this study, we examined the expression of the messenger RNA (mRNA) of the nuclear proto-oncogenes c-fos and c-yun in 10 early (6-10 weeks) and 20 term (30-40 weeks) pregnancy decidua by Northern blotting. In order to investigate the relationship between ER and these proto-oncogenes, the ER and progesterone receptors (PR) were identified in the same tissue samples by immunohistochemistry. When using 30-mer oligonucleotide probes, hardly any signals for c-fos and c-jun could be identified either in early or in late pregnancy decidua. Nuclear ER staining was intense in the epithelium and stroma of proliferative and early to mid-secretory endometrium but was sparsely scattered in stroma and lacking in epithelium during early pregnancy. In late pregnancy decidua, no positive ER staining was detectable. PR were present in abundance both in endometrial epithelium and stroma in proliferative and early secretory phase, and clear positive staining remained in stromal cells in late secretory phase and throughout pregnancy. The temporal association between immunoreactive ERs and the expression of c-fos and c-jun mRNA suggests that the activation of both proto-oncogenes is ER-mediated in human endometrium. The down-regulation of ER is one possible explanation for the repression of these immediate early genes during pregnancy.
Introduction
The cell growth and differentiation are controlled by a number of regulatory factors, including steroid hormones and peptide growth factors. It is becoming increasingly evident that nuclear proto-oncogenes play a key role in co-ordinating steroid hormone actions in different tissues (Schuchard et al, 1993) . Oestrogen induces nuclear proto-oncogenes c-fos, c-jun and c-myc in several oestrogen receptor (ER) positive cells, and an oestrogen responsive element (ERE) has been located in the promoter region of c-fos gene (Weisz and Rosales, 1990) . The increased expression of c-jun has been assumed to be a primary response to oestrogen and mediated directly through the ER, because it is not eliminated by protein synthesis inhibitors . ER-mediated activation of early immediate genes can occur via different routes, and these signalling pathways have been shown to be species-specific, and within the species, they seem to be tissue-and cell-specific (Landers and Spelsberg, 1992) . Oncoproteins C-Jun and C-Fos are a part of the nuclear activator protein-1 (AP-1) complex which induces transcription of several genes and is thus involved in many rapid cellular events such as proliferation, differentiation and apoptosis (Curran and Franza, 1988; Ryseck et al, 1988; Weisz and Rosales, 1990; Colotta et al, 1992; Ambrosino et al, 1993) .
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Only few animal studies exist on proto-oncogene expression in non-malignant endometrium. 17-fi-oestradiol increases c-fos and c-jun in rat uterus, and immunohistochemical studies with polyclonal antibodies have revealed that oestrogen induces both C-Fos and C-Jun proteins in the luminal and glandular epithelium of ovariectomized rats Papa et al, 1991; Webb et al., 1993) . Data from recent studies with rats suggest that c-jun is involved in endometrial decidualization rather than proliferation because in-situ hybridization studies have shown that oestrogen represses the expression of c-jun in the luminal epithelium and progesterone is capable of blocking this oestrogen effect (Bigsby and Li, 1994; Nephew et al., 1994) . In contrast, c-fos is stimulated both in epithelium and stroma by oestrogen in rat uterus. Later studies have demonstrated that tamoxifen has similar effects as oestrogen on rat epithelial c-jun and c-fos expressions (Nephew et al, 1996) . In porcine and mouse endometrium, c-fos and C-Fos protein are induced around the peri-implantation period, and in pregnant sheep, c-fos stimulation is associated with endometrial proliferation (Baker et al, 1992; Dubois et al, 1993; Zheng et al, 1996) . On the other hand, in experimental conditions C-Jun represses the placental human chorionic gonadotrophin (HCG) gene activation that is essential for maintaining pregnancy (Pestell et al, 1994 Northern blot analysis that c-fos and c-jun are strongly expressed in human proliferative and mid-secretory phase endometrium (Salmi and Rutanen, 1996) . In this study, we examined the steady state expression of c-fos and c-jun mRNA in human decidua during early and late pregnancy. In order to clarify the dependence of the expression of these protooncogenes on ER in human endometrium, the ER and PR in the same tissue specimens were examined by immunohistochemistry.
Materials and methods
All tissue specimens were collected at the Department of Obstetrics and Gynaecology, Helsinki University Central Hospital, Finland. Ten samples of non-pregnant endometrium, five from proliferative and five from secretory phase, were collected from women who underwent hysterectomy for benign uterine leiomyomas. The stage of the menstrual cycle was determined on the basis of the patients' menstrual history and confirmed by histological dating of the endometrium according to the criteria of Noyes et al. (1950) . Ten decidua] samples were collected from women who underwent legal abortion for social reasons at 6-10 weeks gestation. No prostaglandin analogues or other local medication were used before dilatation and curettage by suction. In addition, samples of decidua were obtained from 20 healthy women at elective Caesarean section at 30-40 weeks gestation. None of the women had uterine contractions or any medication. The samples for RNA extraction were frozen in liquid nitrogen and stored at -80°C until further processing. A piece of each tissue sample was fixed in formaline and embedded in paraffin wax for immunohistochemical studies. The origin and homogeneity of the frozen tissue samples were confirmed by histological analyses in each case. The study was done with the approval of the hospital ethical committee.
RNA extraction and Northern analysis
The total cellular RNA from the tissue samples was isolated with acidguanidium-thiocyanate-phenol-chloroform extraction (Chomczynski and Sacchi. 1987) , and the RNA concentration of the samples was determined spectrophotometrically. For Northern blot analysis, the total RNA samples were size-fractioned on a 1% agarose gel containing formaldehyde and transferred to nylon filters (Hybond-N; Amersham International, Amersham, Bucks, UK). An RNA ladder (Promega Corp., Madison, WI, USA) was run for RNA sizing. The filters were prehybridized at 65°C for 1-2 h and hybridized at 65°C for 24 h. The oligonucleotide hybridization solution contained 10% dextran sulphate, 1 M NaCI, 25 u.g/ml tRNA (Boehringer Mannheim, Mannheim, Germany), and 1% sodium dodecyl sulphate (SDS). The probes were 3'-end labelled with [a-32 P]-dCTP (6000 Ci/mmol; Amersham) and terminal-transferred (terminal transpherase 500 IU, Boehringer Mannheim) and purified (Nick™ Column; Pharmacia Biotech, Uppsala, Sweden). The hybridized filters were washed in O.IXSSC (1XSSC is 0.15 mol NaCl/1 and 0.015 mol sodium citrate/ 1) with 0.1 % SDS (three times for 20 min at 60°C). Thereafter, the filters were subjected to autoradiography using Kodak X-omatic Regular intensifying screens and Kodak XAR-2 films at -80°C for 2-24 h. An antisense 26-nt probe to the human 28S ribosomal RNA (rRNA) was used to normalize the amount of RNA loaded in each lane (Barbu and Dautry, 1989) . A synthetic 30-mer oligonucleotide probe for insulin-like growth factor binding protein-1 (IGFBP-1) was used to confirm that the tissues examined expressed a gene specific to the decidua (Koistinen et al, 1986) . showing c-jun expression in one proliferative phase endometrium, in five early (range 7-10 weeks) and five late (range 39-40 weeks) pregnancy decidual samples and in one early secretory phase endometrium. In non-pregnant endometrium, two mRNA transcripts (2.7 kb and 3.4 kb) for c-jun are detectable. 18 ug of total RNA was loaded in each lane, and the autoradiographic exposure time was 24 h for c-jun and 2 h for 28S rRNA (loading control), e = endometrium; prol = proliferative phase; seer = secretory phase; d = decidua; early preg = early pregnancy; late preg = late pregnancy. showing c-fos expression in one proliferative phase endometrium, in five early (range 7-10 weeks) and five late (range 39^t0 weeks) pregnancy decidual samples and in one early secretory phase endometrium. The blot was sequentially probed with oligonucleotides for c-fos, IGFBP-1 (positive control for decidua) and human 28S rRNA. A 2.2 kb transcript for c-fos is detectable in the cycling endometrium and a 1.5 kb transcript for IGFBP-1 in decidualized endometrium respectively. 18 ug of total RNA was loaded in each lane, and autoradiographic exposure time was 24 h for c-fos, 4 h for IGFBP-1 and 2 h for 28S rRNA. e = endometrium; prol = proliferative phase; seer = secretory phase; d = decidua; early preg = early pregnancy; late preg = late pregnancy.
TGAG and for the c-fos mRNA CATGGTCTTCACAAC-GCCAGCCCTGGAGTA (1357-86). The probes were based on previously published sequences of human c-jun and c-fos genes (van Straaten et al.. 1983; Hattori et al., 1988) . The 26-mer oligo for human 28S rRNA, used as a loading control in Northern blotting, was AACGATCAGAGTAGTGGTATTTCACC (Koistinen et al., 1986) and the 30-mer oligo for the human IGFBP-1 mRNA was GACAGTCAGCAGGAGCAGTACC AGCC AGAC (Brinkman et al., 1988) . Probes were synthesized at the Research Laboratory of the Department of Obstetrics and Gynaecology, Helsinki University Central Hospital, Finland.
Immunohistochemistry
The detection of ER and PR was carried out with monoclonal mouse anti-human antibodies to ER (Dako ER; Dako, Glostrup, Denmark) and PR (Novocastra Laboratories Ltd., Newcastle-upon-Tyne, UK). The ABC immunoperoxidase staining was carried out by using ABComplex/AP kit (Dako) for both receptors. The formalin-fixed, paraffin wax-embedded tissue sections (5 (im) were deparaffinized in xylene and rehydrated by sequential incubation in ethanol. The deparaffinized tissue sections were pretreated with 10 mM citrate buffer in a microwave oven for 2X5 min and left in the buffer at room temperature for 20 min before the staining procedure. All washings were performed using 0.01 M phosphate-buffered saline, pH 7.4. The sections were treated with 1.0% hydrogen peroxide in methanol for 5 min to quench the endogenous peroxidase activity, and blocked with normal goat serum (1:20) (Vector Laboratories Inc., Burlingame, CA, USA) for 20 min to reduce non-specific binding of antibodies. A primary antibody diluted in phosphate-buffered saline (ER 1:800, PR 1:500) was added and the sections were incubated overnight at 4°C. After rinsing, biotinylated second step goat antimouse immunoglobulins (Dako) were added (1:100) for 30 min, followed by an ABC reagent (1:100) for 40 min. The sites of antibody binding were demonstrated by developing the peroxidase reaction with 3-amino-9-ethyl-carbazole in acetate buffer, pH 5, containing 0.03% hydrogen peroxide, for 15 min. The sections were rinsed with water and counterstained with diluted haematoxylin. For each tissue section, a negative control was stained by replacing the first antibody with an inappropriate monoclonal antibody of the same immunoglobulin class as the monoclonal antibody to the receptor in question.
Results

Decidual c-jun and c-fos mRNA expression during pregnancy
The steady state expression of c-fos and c-jun was investigated from the tissue samples of 10 early pregnancy and from 20 late pregnancy decidua. Cycling endometrium was used as the positive control in each experiment. When using 30-mer oligonucleotides in Northern blot hybridizations, mRNA expressions of both c-fos and c-jun were weak or undetectable in all 30 decidual samples, and the expression did not differ between early and late pregnancy or between different gestational weeks (Figures 1 and 2) . In all cycling endometria, two transcripts of 2.7 kb and 3.4 kb size for c-jun and one of 2.2 kb for c-fos were detected, confirming that hybridization had succeeded. When using a 30-mer oligo for IGFBP-1, a marker of decidual cells (Koistinen et al, 1986) , a 1.5 kb transcript was detected in all decidual samples but not in the cycling endometrium (Figure 2 ).
ER and PR proteins in cycling endometrium and pregnancy decidua
Immunohistochemical analyses with monoclonal mouse antihuman antibodies to ER and PR were carried out on five proliferative and five secretory phase endometria, and on eight early and five late pregnancy decidua (Figures 3 and 4) . Both 982 receptors are nuclear proteins, and only nuclear staining was considered specific to them. Intense and frequent immunohistochemical staining for ER was detected in the luminal and glandular epithelium in the proliferative phase and early to mid-secretory phase endometrium (Figure 3 ). Some positivity for ER was still detected in epithelial and stromal cells in the late secretory endometrium. In the early pregnancy decidua, ER positivity was sparsely scattered in stroma, whereas epithelial cells were negative (Figure 4) . Practically no positive ER staining was detected in the term pregnancy decidua ( Figure  4 ). PR were present both in the epithelium and the stroma in proliferative and early to mid-secretory endometrium ( Figure  3 ). In decidua, intense staining for PR was detected in stromal cells throughout gestation but the epithelial cells were negative (Figure 4 ).
Discussion
In a previous work we have demonstrated a strong expression of c-jun and c-fos mRNAs in human proliferative and early to mid-secretory endometrium (Salmi and Rutanen, 1996) . In this study, we show that both the c-jun and c-fos mRNA expressions are down-regulated in human decidua throughout pregnancy. Because these proto-oncogenes are ER complex-regulated in many tissues, we studied the presence of ER and PR in the same tissue samples by immunohistochemistry. In agreement with the previous studies, both the intensity and the cellular location of ER and PR immunoreactivity were found to change depending on the hormonal status of the endometrium (Garcia et al, 1988; Lessey et al., 1988; Perrot-Applanat et al, 1994; Noci et al, 1994) . The ER immunoreactivity was strongest in the epithelial cells in the proliferative and early to midsecretory phase endometrium, it was localized in few stromal cells in the early pregnancy decidua, and was almost completely lacking in the late pregnancy decidua. In contrast, the PR immunostaining which was detected in both the epithelial and stromal cells in the non-pregnant endometrium remained intense in the endometrial stromal cells throughout pregnancy. Taken together, the results of our previous and present studies, demonstrating that c-fos and c-jun mRNAs are abundantly expressed in the proliferative and early to mid-secretory endometrium and down-regulated in human pregnancy decidua in parallel with the changes of ER immunoreactivity in these tissues, strongly suggest that c-fos and c-jun are regulated by the ER complex also in the human endometrium. Oestrogen is the major stimulatory factor in endometrial cell proliferation (Dallenbach-Hellweg, 1987; Bulletti et al, 1994) . Oestrogen-modulation of gene transcription may occur through different cellular elements and is suggested to be cell type-specific (Landers and Spelsberg, 1992; Webb etal, 1995) . A model has been proposed in which the steroid receptor binds to 'early' regulatory genes, the protein products of which then regulate the 'late' structural genes (Landers and Spelsberg, 1992) . Nuclear proto-oncogenes, including c-fos and c-jun, are one class of the early-regulated genes. Stimulation of early genes c-fos and c-jun by oestrogen is supposed to be a direct primary response to the hormone, since it is not blocked by protein synthesis inhibitors (Weisz and Rosales, 1990; .
The physiological role of c-fos and c-jun in the human endometrium is so far unknown. C-fos expression coexists with oestrogen-induced proliferation in porcine and mouse uterus during implantation (Baker et al, 1992; Dubois et al, 1993) . Recently, Zheng et al. (1996) demonstrated that c-fos expression is inversely correlated with the ER status in pregnant ewes and suggested that the induction of c-fos is related to endometrial cell proliferation. It has also been reported that oestrogen and anti-oestrogen tamoxifen inhibit the c-jun activation in the endometrial epithelial cells of ovariectomized rats, and that progesterone neutralizes this effect (Bigsby and Li, 1994; Nephew et al, 1994 Nephew et al, , 1996 . The agonist action of tamoxifen is thought to be mediated through AP-1 sites on oestrogen responsive genes, e.g. c-fos (Webb et al., 1995) . Interestingly, the agonist action is lacking in breast tissue. However, one must be cautious when generalizing the results of animal studies to humans, because the endometrial physiology and the type of implantation differ between species (Bell, 1985; Lindenberg, 1991) . As shown by us and others, the ER concentration increases in the human endometrium concomitantly with increasing cell proliferation and is low in terminally differentiated pregnancy decidua (Garcia et al, 1988; Lessey et al, 1988; Perrot-Applanat et al, 1994) . Our observations of the c-fos and c-jun expressions are in favour of the role of these proto-oncogenes in co-ordinating the events that lead to oestrogen-mediated cell proliferation in human endometrium. Due to the suppression of the c-jun mRNA expression in the pregnancy decidua, the role of c-jun as a mediator of decidualization, as suggested by rat studies (Bigsby and Li, 1994; Nephew et al, 1994) , is unlikely in humans.
Several studies have reported suppression of nuclear protooncogenes by sex steroids (Lau et al, 1990; Kirkland et al., 1993; Schuchard et al, 1993; Subramaniam et al, 1993) . Both oestrogen and progesterone down-regulate c-jun in avian oviduct while oestrogen increases the c-jun mRNA levels in avian liver (Lau et al, 1990; Subramaniam et al, 1993) . Moreover, in some cells the c-jun expression is increased while it is decreased in other cells by glucocorticoids (Zhou and Thompson, 1996) . The glucocorticoid receptor and the PR have a high mutual homology, and both receptors have been shown to bind to the same enhancer DNA sequences (Cato et al, 1986; Landers and Spelsberg, 1992) . Most studies on the progesterone regulation of nuclear proto-oncogenes have shown either a decrease in the gene expression or no effect (Landers and Spelsberg, 1992) . For example, progesterone inhibits the oestrogen-induced expression of c-fos in rat uterus (Kirkland et al, 1993) . Although no progesterone-responsive elements have been located in c-jun and c-fos genes, the decidual depression of c-jun and c-fos now noticed in humans could be induced by progesterone. This might be an indirect effect via the down-regulation of ER by progesterone (Levy et al, 1980; Padayachi et al, 1990) . It is also possible that progesterone regulates the proto-oncogene expression through protein-protein interactions between its receptor complex and the transcriptional machinery. Conversely, the transcription factor AP-1, a hetero/homodimer of C-Fos and C-Jun proteins, has been shown to down-regulate PR (Savouret et al, 1994) . This is in accordance with our findings on the human decidua, in which PRs are present and c-fos and c-jun suppressed throughout pregnancy. Yet, our data cannot rule out the presence of some pregnancy-specific inhibitory factor which could be responsible for the proto-oncogene suppression, as speculated previously by Blumenthal et al (1993) . It is also possible that locally produced growth factors and related proteins are involved in the suppression of c-fos and c-jun in pregnant endometrium. For example, IGFBP-1 which is induced by progesterone and inhibits the biological action of insulin-like growth factor-I (Rutanen et al, 1988) , is absent in proliferative and early to mid-secretory endometrium but strongly expressed in pregnancy decidua opposite to c-fos and c-jun expressions, as shown in our present study.
In summary, we now show for the first time that the expression of c-fos and c-jun mRNA is suppressed in human endometrium during pregnancy, paralleling the disappearance of ERs. The temporal relationship between the expression of c-fos and c-jun and the ER protein supports the hypothesis that c-fos and c-jun are activated through the ER complex in human endometrium and that these proto-oncogenes are potential contributors to the oestrogen-induced signal transduction in this tissue.
